Hospital groups raise issues with 340B rebate pilot program citing cash flow, administrative costs, and unclear rebate denials risks.

Recent data released by the Health Resources and Services Administration show that drug purchases made under the 340B Drug Pricing Program totaled $81.4 billion in 2024.

Hospital groups warn the 340B rebate pilot would force safety net providers to front tens of millions of dollars for drugs ...

Hospital groups are calling for the federal government to take action after Johnson & Johnson warned it will require 340B-eligible providers to pay full price up front for two widely prescribed ...

St. Mary's in Lewiston is a plaintiff in the suit, which targets a pilot program introduced by the Trump administration.

In August, J&J informed disproportionate share hospitals, which care for a large number of vulnerable patients, that it would stop giving them upfront discounts on plaque psoriasis treatment Stelara ...

The vast majority of hospitals that participate in the 340B drug pricing program do not follow recent hospital transparency regulations requiring them to report the prices they charge for oncology ...

In politics, there is far too often far too much focus on what’s happening in Washington, D.C. and whatever Beltway politicians and the national media deem to be the “news of the day.” ...